Major histocompatibility complex class I molecule selves as a ligand for presentation of the superantigen staphylococcal enterotoxin B to T cells

被引:22
|
作者
Haffner, AC [1 ]
Zepter, K [1 ]
Elmets, CA [1 ]
机构
[1] CASE WESTERN RESERVE UNIV HOSP, DEPT DERMATOL, SKIN DIS RES CTR, CLEVELAND, OH 44106 USA
关键词
D O I
10.1073/pnas.93.7.3037
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Superantigens, such as staphylococcal enterotoxin B (SEE), elicit a strong proliferative response in T cells when presented in the context of major histocompatibility complex (MHC) class II molecules. We observed a similar T-cell response, when MHC class II-negative epidermal cell lines were employed as antigen-presenting cells, Immunoprecipitation studies indicated that the ligand to which SEE bound had a molecular mass of 46 kDa, Radiolabeled SEE could be immunoprecipitated from isolated membrane proteins on the SCC13 epidermal cell line with a monoclonal antibody directed against the MHC class I molecule, and transfection of the K-562 cell line with MHC class I molecules showed a 75% increased SEE-binding capacity compared with the nontransfected MHC class I- and class II-negative counterpart, In functional studies, antibodies to the MHC class I molecule inhibited T-cell proliferation by at least 50%, From these studies, we conclude that MHC class I molecules on malignant squamous cell carcinomas serve as ligands for SEE, which, given the appropriate costimulatory signals, is sufficient to allow for superantigen-induced T-cell proliferation.
引用
收藏
页码:3037 / 3042
页数:6
相关论文
共 50 条
  • [21] Zinc induces dimerization of the class II major histocompatibility complex molecule that leads to cooperative binding to a superantigen
    Li, Hongmin
    Zhao, Yiwei
    Guo, Yi
    Li, Zhong
    Eisele, Leslie
    Mourad, Walid
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (09) : 5991 - 6000
  • [22] Differential immune responses to staphylococcal Enterotoxin B mutations in a hydrophobic loop dominating the interface with major histocompatibility complex class II receptors
    Woody, MA
    Krakauer, T
    Ulrich, RG
    Stiles, BG
    JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04): : 1013 - 1022
  • [23] A SOLUBLE DIVALENT CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE INHIBITS ALLOREACTIVE T-CELLS AT NANOMOLAR CONCENTRATIONS
    DALPORTO, J
    JOHANSEN, TE
    CATIPOVIC, B
    PARFIIT, DJ
    TUVESON, D
    GETHER, U
    KOZLOWSKI, S
    FEARON, DT
    SCHNECK, JP
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (14) : 6671 - 6675
  • [24] PEPTIDE PRESENTATION BY CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX-MOLECULES
    NIKOLICZUGIC, J
    CARBONE, FR
    IMMUNOLOGIC RESEARCH, 1991, 10 (01) : 54 - 65
  • [25] PRESENTATION OF AN EXOGENOUS ANTIGEN BY MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES
    ULMER, JB
    DONNELLY, JJ
    LIU, MA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (07) : 1590 - 1596
  • [26] Major histocompatibility complex class I-restricted antigen processing and presentation
    Van Kaer, L
    TISSUE ANTIGENS, 2002, 60 (01): : 1 - 9
  • [27] Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation
    Yang, Y
    Sempe, P
    Peterson, PA
    IMMUNOLOGIC RESEARCH, 1996, 15 (03) : 208 - 233
  • [28] REGULATION OF RECEPTOR INTERNALIZATION BY THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULE
    OLSSON, L
    GOLDSTEIN, A
    STAGSTED, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) : 9086 - 9090
  • [29] CELL BIOLOGY OF ANTIGEN-PROCESSING AND PRESENTATION TO MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULE-RESTRICTED T-LYMPHOCYTES
    YEWDELL, JW
    BENNINK, JR
    ADVANCES IN IMMUNOLOGY, 1992, 52 : 1 - 123
  • [30] Three-dimensional structure of the complex between a T cell receptor β chain and the superantigen staphylococcal enterotoxin B
    Li, HM
    Llera, A
    Tsuchiya, D
    Leder, L
    Ysern, X
    Schlievert, PM
    Karjalainen, K
    Mariuzza, RA
    IMMUNITY, 1998, 9 (06) : 807 - 816